Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 7NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 5Neoplasm Metastasis 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Radiation Injuries 1Precancerous Conditions 1Papillomavirus Infections 1Pancreatic Adenocarcinoma 1Ovarian Neoplasms 1Neoplasms 1Head and Neck Neoplasms 1Gallbladder Neoplasms 1Fallopian Tube Neoplasms 1Cholangiocarcinoma 1Carcinoma 1Anatomic Stage II Breast Cancer AJCC v8 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1Adenocarcinoma 1

Interventions

dehydroftorafur 1Taxes 1Pancreatectomy 1Oxaliplatin 1Irinotecan 1Gemcitabine 1Fluorouracil 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Pancreatic Adenocarcinoma × Albumin-Bound Paclitaxel × Clear all
NCT02562716 2022-10-19

S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

SWOG Cancer Research Network

Phase 2 Completed
147 enrolled 16 charts
Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡